scholarly article | Q13442814 |
P356 | DOI | 10.1002/AJH.23530 |
P698 | PubMed publication ID | 23828018 |
P2093 | author name string | Jaroslaw P Maciejewski | |
Mikkael A Sekeres | |||
Sudipto Mukherjee | |||
Matt E Kalaycio | |||
Ramon V Tiu | |||
Anjali S Advani | |||
Marc Earl | |||
Candice M Wenzell | |||
Jun-Yen Yeh | |||
Erika M Gallagher | |||
Karissa N Kusick | |||
P2860 | cites work | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) | Q28209814 |
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese | Q33303164 | ||
Actual body weight for determining doses of chemotherapy in obese cancer patients: evaluation of treatment tolerability | Q33358496 | ||
Effects of obesity on pharmacokinetics implications for drug therapy | Q34053786 | ||
Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines | Q34459673 | ||
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline | Q34637194 | ||
Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA). | Q34856664 | ||
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia | Q35671452 | ||
Is obesity a prognostic factor for acute myeloid leukemia outcome? | Q35749864 | ||
Mortality in overweight and underweight children with acute myeloid leukemia | Q36006255 | ||
Weight-based chemotherapy dosing in obese patients with cancer: back to the future | Q36095287 | ||
Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia | Q36216242 | ||
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia | Q40543180 | ||
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients | Q47201592 | ||
P433 | issue | 10 | |
P921 | main subject | obesity | Q12174 |
leukemia | Q29496 | ||
acute myeloid leukemia | Q264118 | ||
chemotherapy | Q974135 | ||
P304 | page(s) | 906-909 | |
P577 | publication date | 2013-08-30 | |
P1433 | published in | American Journal of Hematology | Q4744246 |
P1476 | title | Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight | |
P478 | volume | 88 |